A less common case of anti-MDA5 and anti-Ro52 antibody-positive juvenile dermatomyositis complicated with macrophage activation syndrome

被引：0
|
作者：
Zhang, Li [1 ]
Zhang, Haiqing [2 ]
Liu, Shanshan [2 ]
Zhang, Ning [2 ]
Wang, Yun [2 ,3 ]
机构：
[1] Qingdao Univ, Sch Basic Med, Dept Immunol, Qingdao, Peoples R China
[2] Qingdao Women & Childrens Hosp, Clin Lab, Qingdao, Peoples R China
[3] Qingdao Women & Childrens Hosp, Clin Lab, Qingdao 266034, Shandong, Peoples R China
来源：
CLINICAL CASE REPORTS | 2024年 / 12卷 / 03期
关键词：
anti-MDA5; antibody; anti-Ro52; interstitial lung disease; juvenile dermatomyositis; macrophage activation syndrome;
D O I：
10.1002/ccr3.8613
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Clinical utility of anti-Ro52 antibody confirmation in anti-MDA5 antibody-positive dermatomyositis: A case report
    Kodera, Hitoshi
    Hirano, Reina
    Akiyama, Masahiro
    Matsumoto, Yoshifuji
    MODERN RHEUMATOLOGY CASE REPORTS, 2024, 8 (02) : 291 - 295
  • [2] Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum
    Yashiro, Makiko
    Asano, Tomoyuki
    Sato, Shuzo
    Kobayashi, Hiroko
    Watanabe, Hiroshi
    Miyata, Masayuki
    Migita, Kiyoshi
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2018, 64 (02) : 89 - 94
  • [3] Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk
    Lv, Chengyin
    You, Hanxiao
    Xu, Lingxiao
    Wang, Lei
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Zhou, Shiliang
    Da, Zhanyun
    Qian, Jie
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Wang, Yan
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Wang, Fang
    Zhang, Miaojia
    Tan, Wenfeng
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (02) : 219 - 226
  • [4] Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis
    Kogami, Masahiro
    Abe, Yoshiyuki
    Ando, Taiki
    Makiyama, Ayako
    Yamaji, Ken
    Tamura, Naoto
    RHEUMATOLOGY, 2023, 62 (07) : 2525 - 2533
  • [5] New therapies in anti-MDA5 antibody-positive dermatomyositis
    Yasui, Masahiro
    Iwamoto, Taro
    Furuta, Shunsuke
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (01) : 61 - 68
  • [6] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Wang, Huyan
    Chen, Xin
    Du, Yan
    Wang, Lihua
    Wang, Qiyuan
    Wu, Huaxiang
    Liu, Lei
    Xue, Jing
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [7] Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers
    Gul, Busra Demirbag
    Senturk, Nilgun
    Baycelebi, Deniz
    Yildiz, Levent
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2022, 56 (04): : 193 - 196
  • [8] Anti-MDA5 antibody-positive bullous dermatomyositis with thyroid carcinoma
    Hayami, Takuma
    Teramura, Kazuya
    Tanaka, Toshihiro
    Fujimoto, Noriki
    EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (03) : 418 - 419
  • [9] Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
    Gono, Takahisa
    Sato, Shinji
    Kawaguchi, Yasushi
    Kuwana, Masataka
    Hanaoka, Masanori
    Katsumata, Yasuhiro
    Takagi, Kae
    Baba, Sayumi
    Okamoto, Yuko
    Ota, Yuko
    Yamanaka, Hisashi
    RHEUMATOLOGY, 2012, 51 (09) : 1563 - 1570
  • [10] Mortality risk in patients with anti-MDA5 antibody-positive dermatomyositis: A risk assessment
    Kawada, Tomoyuki
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
12345